Italia markets closed

Phreesia, Inc. (0A23.L)

LSE - LSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
23,04+1,51 (+7,01%)
Alla chiusura: 03:19PM BST

Phreesia, Inc.

1521 Concord Pike
Suite 301 PMB 221
Wilmington, DE 19803
United States
(888) 654-7473
https://www.phreesia.com

Settore/i
Settore
Impiegati a tempo pieno1.438

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. Chaim IndigCo-Founder, CEO & Director515k1,75M1979
Mr. Evan RobertsCo-Founder & COO400kN/D1979
Mr. David LinetskySenior Vice President of Life Sciences551,64kN/D1980
Mr. Balaji GandhiChief Financial OfficerN/DN/D1974
Ms. Janet M. GunzburgVP, Principal Accounting Officer & ControllerN/DN/D1966
Mr. Jack CallahanChief Technology OfficerN/DN/DN/D
Ms. Allison C. HoffmanGeneral Counsel & Secretary418,96kN/D1971
Ms. Maureen McKinneyVice President of Corporate CommunicationsN/DN/DN/D
Ms. Kharen HauckVice President of MarketingN/DN/DN/D
Ms. Amy Beth VanDuynSenior Vice President of Human ResourcesN/DN/D1973
Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.

Governance aziendale

L'ISS Governance QualityScore di Phreesia, Inc. al 1 maggio 2024 è 7. I criteri di valutazione fondamentali sono revisione: 7; Consiglio di Amministrazione: 6; diritti degli azionisti: 8; retribuzione: 6.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.